mogamulizumab-kpkc (Poteligeo)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

Adverse effects

common

serious

Mechanism of action

More general terms

References

  1. RxNorm
  2. FDA News Release. Aug 8, 2018 FDA approves treatment for two rare types of non-Hodgkin lymphoma. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm616176.htm